Home Stock

Stock Research: Boryung Pharmaceutical

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

Boryung Pharmaceutical

KOSE:A003850 KR7003850005
76
  • Value
    57
  • Growth
    24
  • Safety
    Safety
    72
  • Combined
    58
  • Sentiment
    88
  • 360° View
    360° View
    76
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Boryung Corp, formerly Boryung Pharm Co Ltd, is a Korea-based pharmaceutical company that manufactures and sells various pharmaceutical products. The company operates in the pharmaceutical industry, producing and distributing drugs such as antihypertensive drugs, gastrointestinal disorder drugs, antibiotics, and anticancer drugs. It distributes its products in domestic and overseas markets. In the last fiscal year, the company had a market cap of $524 million, profits of $246 million, and revenue of $689 million. The number of employees is not available.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 76 (better than 76% compared with alternatives) for 2025, overall professional sentiment and financial characteristics for the stock Boryung Pharmaceutical are very positive. The 360° View is based on consolidating four consolidated indicators, with half of the indicators below and half above average for Boryung Pharmaceutical. The consolidated Value Rank has an attractive rank of 72, which means that the share price of Boryung Pharmaceutical is on the lower side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is lower than for 72% of alternative stocks in the same industry. The company is also safely financed with a Safety rank of 57. In addition, professional market sentiment is above average compared with other stock investment alternatives with a Sentiment Rank of 88. But the consolidated Growth Rank has a low rank of 24, which means that the company is below average in terms of growth and momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. 76 of its competitors have better growth. ...read more

more
Country South Korea
Industry Pharmaceuticals
Size Small
Website boryung.co.kr
Index
KOSPI
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 21-Aug-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Growth
Shows a company's growth potential.
High Growth Tough Times
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
72 52 48 37
Growth
24 51 83 41
Safety
Safety
57 30 28 28
Sentiment
88 90 92 75
360° View
360° View
76 86 75 31
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
100 100 100 87
Opinions Change
50 50 50 18
Pro Holdings
n/a 50 56 82
Market Pulse
82 72 80 n/a
Sentiment
88 90 92 75
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
72 52 48 37
Growth
24 51 83 41
Safety Safety
57 30 28 28
Combined
58 51 48 16
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
73 63 44 40
Price vs. Earnings (P/E)
85 80 85 65
Price vs. Book (P/B)
64 48 42 35
Dividend Yield
35 32 35 36
Value
72 52 48 37
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
52 54 72 55
Profit Growth
24 13 41 64
Capital Growth
68 98 95 49
Stock Returns
26 38 57 23
Growth
24 51 83 41
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
41 37 27 16
Refinancing
90 46 59 69
Liquidity
30 60 34 34
Safety Safety
57 30 28 28

Similar Stocks

Discover high‑ranked alternatives to Boryung Pharmaceutical and broaden your portfolio horizons.

Japan Airlines

TSE:9201
Country: Japan
Industry: Airlines
Size: X-Large
Full Stock Analysis

Korea Investment

KOSE:A071050
Country: South Korea
Industry: Investment Banking & Brokerage
Size: Large
Full Stock Analysis

Kia Motors

KOSE:A000270
Country: South Korea
Industry: Automobile Manufacturers
Size: Large
Full Stock Analysis

Tsumura

TSE:4540
Country: Japan
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis
OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.